PPA
ATRC icon

Parametric Portfolio Associates’s AtriCure ATRC Stock Holding History

Parametric Portfolio Associates’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.76M Buy
42,075
+5,297
+14% +$343K ﹤0.01% 2244
2021
Q4 		$2.56M Buy
36,778
+1,318
+4% +$95.8K ﹤0.01% 2291
2021
Q3 		$2.47M Sell
35,460
-20,824
-37% -$1.6M ﹤0.01% 2321
2021
Q2 		$4.46M Buy
56,284
+24,100
+75% +$1.75M ﹤0.01% 1922
2021
Q1 		$2.11M Sell
32,184
-232
-0.7% -$14.3K ﹤0.01% 2745
2020
Q4 		$1.8M Sell
32,416
-4,199
-11% -$182K ﹤0.01% 2724
2020
Q3 		$1.46M Sell
36,615
-19,059
-34% -$808K ﹤0.01% 2687
2020
Q2 		$2.5M Buy
55,674
+552
+1% +$24K ﹤0.01% 2362
2020
Q1 		$1.85M Buy
55,122
+41,767
+313% +$1.5M ﹤0.01% 2430
2019
Q4 		$434K Buy
13,355
+1,540
+13% +$43.8K ﹤0.01% 3420
2019
Q3 		$295K Sell
11,815
-4,923
-29% -$141K ﹤0.01% 3546
2019
Q2 		$499K Buy
16,738
+1,006
+6% +$29.4K ﹤0.01% 3365
2019
Q1 		$421K Sell
15,732
-34,787
-69% -$1.06M ﹤0.01% 3422
2018
Q4 		$1.55M Buy
50,519
+5,927
+13% +$185K ﹤0.01% 2745
2018
Q3 		$1.56M Sell
44,592
-12,557
-22% -$398K ﹤0.01% 2871
2018
Q2 		$1.55M Buy
+57,149
New +$1.34M ﹤0.01% 2836
2018
Q1 		– Sell
-10,738
Closed -$196K – 3933
2017
Q4 		$196K Sell
10,738
-29,462
-73% -$583K ﹤0.01% 3764
2017
Q3 		$899K Sell
40,200
-20,669
-34% -$467K ﹤0.01% 3096
2017
Q2 		$1.48M Buy
60,869
+26,247
+76% +$558K ﹤0.01% 2741
2017
Q1 		$663K Buy
34,622
+3,488
+11% +$61.1K ﹤0.01% 3065
2016
Q4 		$609K Buy
+31,134
New +$564K ﹤0.01% 3089
2015
Q3 		– Sell
-18,305
Closed -$451K – 3269
2015
Q2 		$451K Buy
18,305
+2,357
+15% +$52.6K ﹤0.01% 3346
2015
Q1 		$327K Hold
15,948
– – ﹤0.01% 3514
2014
Q4 		$318K Hold
15,948
– – ﹤0.01% 3527
2014
Q3 		$235K Buy
15,948
+16
+0.1% +$255 ﹤0.01% 3562
2014
Q2 		$293K Buy
15,932
+367
+2% +$6.11K ﹤0.01% 3532
2014
Q1 		$293K Buy
+15,565
New +$319K ﹤0.01% 3456

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Parametric Portfolio Associates's ATRC Position: Q1 2022 in Review

Parametric Portfolio Associates increased its AtriCure (ATRC) stake by 14% in Q1 2022, buying an estimated $343K and bringing the position to 42,075 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

Parametric Portfolio Associates first reported a position in ATRC in Q1 2014 and has held it in 27 quarters since. The position peaked at $4.46M in Q2 2021. 217 funds tracked by Wall St. Rank hold ATRC as of Q1 2022.

  • Parametric Portfolio Associates held 42,075 shares of AtriCure worth $2.76M as of Q1 2022.
  • Parametric Portfolio Associates bought 5,297 AtriCure shares in Q1 2022, an estimated $343K.
  • AtriCure made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2244 holding.
  • Parametric Portfolio Associates first reported a position in AtriCure in Q1 2014 and has held it in 27 quarters since.
  • Parametric Portfolio Associates's AtriCure position peaked at $4.46M in Q2 2021.
  • 217 funds tracked by Wall St. Rank held AtriCure as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.